Profarma Distribuidora Ownership

PFRM3 Stock  BRL 6.33  0.06  0.94%   
Profarma Distribuidora owns a total of 122.61 Million outstanding shares. Profarma Distribuidora holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.17 pct. of Profarma Distribuidora outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profarma Distribuidora de. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Profarma Stock Ownership Analysis

About 66.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.35. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Profarma Distribuidora last dividend was issued on the 21st of December 2022. The entity had 855:818 split on the 11th of January 2018. Profarma Distrib Prod Farmaceuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil. PROFARMA operates under Medical Distribution classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 6327 people. To find out more about Profarma Distribuidora de contact Sammy Birmarcker at 55 21 4009 0200 or learn more at https://www.profarma.com.br.

Profarma Distribuidora Outstanding Bonds

Profarma Distribuidora issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Profarma Distribuidora uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Profarma bonds can be classified according to their maturity, which is the date when Profarma Distribuidora de has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Profarma Stock Analysis

When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.